Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
Shaheen P Karim, Ron A Adelman Department of Ophthalmology and Visual Science, Yale University, New Haven, CT, USA Abstract: Central serous chorioretinopathy (CSCR) is an idiopathic disorder characterized by serous retinal detachments associated with focal leakage on fluorescein angiography and pigm...
Saved in:
Main Authors: | Karim SP, Adelman RA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/ef90d94ff62d4c9a8c096f752a3dbc31 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
by: Sanguansak T, et al.
Published: (2015) -
Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
by: Alkin Z, et al.
Published: (2014) -
Low-dose aspirin as treatment for central serous chorioretinopathy
by: Antonio Caccavale, et al.
Published: (2010) -
Central serous chorioretinopathy: a pathogenetic model
by: et al, et al.
Published: (2011) -
Transpupillary thermotherapy for atypical central serous chorioretinopathy
by: Kawamura R, et al.
Published: (2012)